Flu Forum: What to Expect in 2021-2022

1.00 CME
1.00 CNE
60 MINS
$0 FEE
SAVE
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Faculty Photo

Overview

Provider Statement

This continuing medical education activity is provided by Vindico Medical Education


Support Statement

This activity is supported by an educational grant from Genentech, a member of the Roche Group.

There is no non-commercial support for this activity.

Education activities are distinguished as separate from endorsement of commercial products. When commercial products are displayed, participants will be advised that accredited status as a provider refers only to its continuing education activities and does not imply ANCC Commission on Accreditation endorsement of any commercial products.


Activity Description

Influenza places a substantial burden on the health of people in the United States each year. Although influenza cases were abnormally low in 2020-2021 during the COVID-19 pandemic, numbers are expected to rebound as we enter the upcoming respiratory virus season. Clinicians who evaluate and treat these patients must keep apprised of new information regarding timely diagnosis and treatment of influenza in order to minimize patient morbidity and mortality. Education is required to facilitate early treatment and optimal use of antivirals. In this CME/CNE/CPE meeting series, Flu Forum: What to Expect in 2021-2022, experts will explore strategies for early diagnosis of influenza using evidence-based guidelines and discuss treatment selection based on patient risk factors and the efficacy and safety of available antiviral therapies. Recommendations and options for post-exposure prophylaxis of influenza will also be discussed. Clinical cases will be presented to highlight the key educational objectives and address challenges in influenza diagnosis and management in the era of COVID-19.


Target Audience

The intended audience for this activity is family medicine physicians, internists, pharmacists, nurse practitioners, physician assistants and other health care professionals involved in the management of patients with influenza.


Learning Objective

Upon successful completion of this educational activity, participants should be better able to:

  • Differentiate influenza from other respiratory conditions by utilizing appropriate diagnostic tools that can detect the disease early in its course.
  • Select antiviral treatment based upon efficacy and safety in patients who are at normal or high risk for complications.
  • Incorporate the use of antiviral prophylaxis when appropriate to reduce the potential for influenza infection.

Activity Co-Chairs

Paul G. Auwaerter, MD, MBA, FIDSA
Sherrilyn and Ken Fisher Professor of Medicine
Clinical Director, Division of Infectious Diseases
Director, Sherrilyn and Ken Fisher Center for Environmental Infectious Diseases
Johns Hopkins University School of Medicine
Baltimore, MD

Margot Savoy, MD, MPH, FAAFP, FABC, CPE, CMQ, FAAPL
Associate Professor, Family & Community Medicine and Center for Urban Bioethics
Lewis Katz School of Medicine at Temple University & Temple University Health System
Philadelphia, PA


Planners & Reviewers

Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
Jennifer Frederick, PharmD, BCPS
Barbara A. Niedz, PhD, RN, CPHQ
Chad Rittle, DNP, MPH, RN, FAAOHN


Accreditation

ACCME logoVindico Medical Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AANCVindico Medical Education is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

Vindico Medical Education is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education.


Credit Designation

Vindico Medical Education designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Successful completion of this CME activity enables the participant to earn up to 1.0 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Participants who opt-in will earn MOC points equivalent to the amount of CME credits claimed for the activity.

Vindico Medical Education will provide a maximum of 1.0 contact hours for nurses. Nurses should claim only the credit commensurate with the extent of their participation in the activity.

This program is acceptable for 1.0 contact hour of Accreditation Council for Pharmacy Education (ACPE) Continuing Education Credit. The ACPE Universal Program Number is 0482-0000-21-027-H01-P, effective 10/29/2021. This is a knowledge-based activity and there is no fee to attend.

Vindico Medical Education will provide pharmacist credits claimed information directly to the ACPE through CPE Monitor within 30 days.

Nurse practitioners can apply for AMA PRA Category 1 Credit(s)™ through the American Academy of Nurse Practitioners Certification Board (AANPCB). AANPCB will accept AMA PRA Category 1 Credit(s)™ from organizations accredited by ACCME.

American Academy of Physician Assistants (AAPA) accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit(s)™ from organizations accredited by the ACCME. Physician assistants may receive a maximum of 1.0 hours credit for completing this program.

This enduring material is approved for 1 year from the date of original release, October 29, 2021 to October 28, 2022.


How to Participate in This Activity and Obtain CE Credit

To participate in this CE activity, you must read the objectives, answer the polling and pretest questions, view the content, and complete the posttest and evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 3 of the 4 posttest questions correctly. Upon receipt of the completed materials, if a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)™ Certificate, Contact Hour Certificate, or CPE Statement of Credit.


Disclosures

In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all accredited providers are required to mitigate and disclose to the activity audience the relevant financial relationships of the planners, teachers, and authors involved in the development of accredited content. Individuals have a relevant financial relationship if they have a financial relationship in any amount occurring in the past 12 months with a commercial interest whose products or services are discussed in the accredited activity content over which the individual has control. Relationship information appears below.  

Actvity Co-Chairs report the following relationship(s)

Paul G. Auwaerter, MD, MBA, FIDSA
Ownership Interest: Johnson & Johnson

Margot Savoy, MD, MPH, FAAFP, FABC, CPE, CMQ, FAAPL
CME Advisory Committee: US Government
Honorarium: Merck Manual

Planners and Reviewers report the following relationship(s)

Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
No relevant financial relationships to disclose.

Jennifer Frederick, PharmD, BCPS
No relevant financial relationships to disclose.

Barbara A. Niedz, PhD, RN, CPHQ
No relevant financial relationships to disclose.

Chad Rittle, DNP, MPH, RN, FAAOHN
No relevant financial relationships to disclose.

Vindico Medical Education staff report the following relationship(s)

No relevant financial relationships to disclose.

Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.


Unlabeled and Investigational Usage

The audience is advised that this continuing medical education activity may contain references to unlabeled uses of US Food and Drug Administration (FDA)–approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non–FDA-approved or investigational use of products/devices.


Copyright Statement

Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2021 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any of Vindico Medical Education continuing medical education activities does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the US Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.


CME Questions?

Contact us at cme@vindicoCME.com